Roche's antiviral meets main goal in late-stage study - Reuters PDF Print

The study was designed to investigate whether extending therapy with Valcyte to 200 days from 100 days post-transplant will further reduce the incidence of ...

read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.